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Cytogenetic and Teratogenic Test of
Polybrominated Biphenyls in Rodents
by Gary F. Wertz*t and Gyula Ficsor*
Previously we reported negative terata and c-mitosis synergism of FireMaster (polybrominated
biphenyls) with cokchicine in subacutely treated rats. Now we report absence ofchromosome aberrations
from FireMaster and absence of c-mitosis synergism of FireMaster and colchicine in male mice.
For the study ofchromosome aberrations groups ofthree mice received 0, 50, or 500 mg/kg FireMaster
or 4.5 mgnkg triethylenemelamine (TEM) dissolved in dimethyl sulfoxide through a single stomach gavage
administr'ation. Five hours before killing the animals were injected with 5 mg colchicine/kg. Groups of 3
mice from each treatment were killed 12, 24, and48 hr after treatment. From the bone marrow ofeach of
36 mice 100 metaphases were scored for gaps, chromatid and chromosome breaks, rearrangements and
pulverized chromosomes. Only TEM induced chromosome damage.
For detection of synergism between FireMaster and colchicine, slides prepared for chromosome
analysis were also scored for metaphase and mitotic indeces. Control mice for detection ofsynergism were
treated as for thechromosome study but were not injected with colchicine. Approximately 1000 cells were
scored from each of72 animals for determination ofmetaphase and mitotic indeces. FireMaster did not
show c-mitosis synergism with colchicine in mice.
Treatment with FireMaster did not cause visually recognizable toxicity.
Introduction
Through accidental contamination of animal feed
with polybrominated biphenyls (PBB) several
hundred Michigan farm families were contaminated
with PBB from animal food products (1). Toxic and
health data on PBB is scarce since PBB was not
meant for animal or human consumption.
Toxic polychlorinated biphenyls (PCBs) (2, 3) are
chemically similar to PBBs. Biological similarity of
PCBs and PBBs is indicated by similar concen-
trations excreted in milk fat of cows (4). PCBs had
no effect on mitotic division or chromosomal aber-
rations in rat bone marrow (5). Previously we re-
ported results with 15 pregnant rats force fed with
100 mg PBB/kg in 1 ml corn oil six times in 2-day
intervals beginning on the day 6 of pregnancy (6).
Fourteen control animals received only corn oil. On
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the day 19 ofpregnancy the animals were killed, and
376 fetuses were weighed, sexed, visually observed
for cleft palates, missing digits, and gross malfor-
mations, and were stained with Alizarin Red S for
skeletal abnormalities. Dead implants were also
counted. For all parameters no difference was
found between control and treated groups. There
was also no difference in the weight gain and gen-
eral health of treated and control animals, but a
synergism ofPBB with colchicine for mitotic arrest
was observed in the bone marrow of pregnant rats
(6).
This report demonstrates the absence ofchromo-
some aberrations or mitotic arrest in bone marrow
ofmale mice treated with PBB. The positive control
triethylenemelamine (TEM) induced a high fre-
quency of chromosome damage.
Materials and Methods
Random bred Upjohn strain Swiss albino male
mice weighing 35+± 2 g were used. The test sample
used in the present and previous investigation (6)
April 1978 129was from a bag of FireMaster (PBB) found in the
grain mill where the contamination occurred and
was acquired from Dr. R. Ringer ofthe Department
Poultry Science ofMichigan State University. TEM
was from Pfaltz and Bayer Inc.
Cytogenetic Analysis of Bone Marrow
For the study ofchromosome aberrations, groups
ofnine mice received 0, 50, or500 mg FireMaster or
4.5 mg TEM/kg dissolved in 0.3 ml dimethyl sulf-
oxide (DMSO) through a single stomach gavage
administration. After extensive trial and error runs
with alcohols and various other organic solvents,
PBB was found to be most soluble in DMSO. The
animals were injected with 5 mg colchicine/kg 5 hr
before killing. Groups of three mice from each
treatment were killed 12, 24, and 48 hr after treat-
ment.
Bone marrow was flushed through each end of
the excised femurs with 1 ml of2.5% sodium citrate
from a syringe with a 23G needle. The bone marrow
cells were suspended and were collected in a Clay
Adams Dynac Centrifuge at 1000 rpm for 5 min. The
supernatant was poured off, leaving about 0.25 ml
of fluid in the test tube. The cells were thoroughly
suspended and 3 ml of 0.56% KCI hypotonic solu-
tion was added and the suspension was incubated in
a 37°C water bath for 20 min. The cells were again
collected by centrifuging at 1000 rpm for 5 min. The
supernatant was removed with a pasteur pipet
leaving approximately 0.25 ml of fluid in which the
cells were resuspended. Then 10 ml offresh fixative
(3 parts absolute methanol: 1 part glacial acetic
acid) was slowly added with constant agitation to
prevent cell clumping. Five aspirations with a pas-
teur pipet aided mixing. The fixative was changed
two times. During the last resuspension approxi-
mately 4 ml fixative was added to give a turbid cell
suspension.
Precleaned microscope slides previously placed
in a freezer were allowed to collect condensation.
Two to four drops of cell suspension were dropped
on each slide from 12-18 in. by use of a pasteur
pipet. The slides were immediately passed through
a flame allowing the methanol to burn completely.
Once completely dry, the slides were flooded for4-5
min with fresh Giemsa stain prepared by mixing 5
ml stock solution, 6 ml acetone, and 100 ml tap
water. The Giemsa stock solution contained 3.6 g
Giemsa powder (Polysciences Inc.) dissolved in 250
ml glycerol and 250 ml methanol. After staining, the
slides were rinsed in distilled water and were dried
with a stream of air. Slides were blind scored for
gaps, chromatid and chromosome breaks, and for
pulverized metaphase spreads under 1000 magnifi-
cation.
To determine possible c-mitotic effect of PBB,
mitotic and metaphase indices were determined
from animals treated as for chromosome analysis,
but without colchicine injection. To detect possible
c-mitosis synergism between PBB and colchicine,
the slides used for chromosome analysis were also
scored for mitotic and metaphase indices.
Statistical Analysis
The significance of differences of chromosome
aberrations and metaphase and mitotic indices in
treated and control groups was determined by the
method of Kastenbaum and Bowman (7).
Table 1. Evaluation of control, PBB, or TEM-treated mouse bone marrow metaphases for chromosome abnormalities
12, 24, and 48 hr after treatment.
No. of cells No. of cells
Total Non- Cells Multiple Cells
no. of Centro- centro- with Chromo- Multiple chromo- Pulver- with
Treatment, Time No. of cells meric meric gaps, Chromatid some Chromatid some ized aber-
mg/kg hr animals scored gaps gaps % break break break breaks cells rations, %
Control 12 3 300 3 2 3.33 2 0 0 0 0 0.66
PBB 50 3 300 12 1 4.33 1 0 0 1 0 0.66
PBB 500 3 300 14 0 4.66 0 1 0 0 0 0.33
TEM 4.5 3 300 6 10 5.33 5 2 16b 0 16b 13.00b
Control 24 3 300 11 0 3.66 0 0 0 0 0 0.00
PBB 50 3 300 20 8a 9.33a 4 0 0 0 0 1.33
PBB 500 3 300 15 2 5.66 1 0 0 0 0 0.33
TEM 4.5 3 300 41b 22b 21.00b 18b 0 15b 0 0 1 00b
Control 48 3 300 2 0 0.66 0 0 0 0 0 0.00
PBB 50 3 300 6 1 2.33 1 0 0 0 0 0.33
PBB 500 3 300 12a I 4.33a 0 0 0 0 0 0.00
TEM 4.5 3 300 54b 8a 20.66b 8a 1lb 1 3 1 8.00
a p < 0.05; significant.
bp < 0.01; highly significant.
Environmental Health Perspectives 130Table 2. Evaluation of control, PBB-, TEM-, or colchicine-treated bone marrow cells for mitotic and metaphase
indices 12, 24, and 48 hr after treatment.
12 hr 24 hr 48 hr
Treatment, Colchicine, No. of No. of cells Cells No. of cells Cells No. of cells Cells
mg/kg mg/kg animals counted in mitosis, % counted in mitosis, % counted in mitosis, %
Mitotic Index
Control 0 3 3035 0.5 3024 0.8 3009 1.4
Control 5 3 3031 4.6 3030 6.7 3021 8.3
PBB 50 0 3 3026 1.2 3010 1.3 3016 1.0
PBB 50 5 3 3027 4.8 3025 3.3 3103 7.0
PBB 500 0 3 3037 1.7 3018 1.4 3025 1.8
PBB 500 5 3 3038 5.7 3027 8.5 3016 6.7
TEM 4.5 0 3 3024 1.0 3030 0.3 3022 1.4
TEM 4.5 5 3 3026 3.7 3016 1.1 3102 4.3
Metaphase Index
Control 0 3 3035 0.0 3024 0.1 3009 0.3
Control 5 3 3031 1.1 3030 1.6 3021 1.6
PBB 50 0 3 3026 0.2 3010 0.2 3016 0.2
PBB 50 5 3 3027 1.2 3025 1.0 3103 2.1
PBB 500 0 3 3037 0.4 3018 0.1 3025 0.2
PBB 500 5 3 3038 1.6 3027 2.4 3016 1.7
TEM 4.5 0 3 3024 0.1 3030 0.0 3022 0.2
TEM 4.5 5 3 3026 0.9 3016 0.3 3102 1.9
Table 3. Evaluation of fetuses from polybrominated biphenyl-treated pregnant rats.
Sex of fetus Average Sex______of____fetus______ No. of weight of Dead
PBB, No. of No. of Males, Females, fetuses fetuses, implants,
mg/kga animals fetuses % % per animal g t
0 14 168 50.6 49.4 12.0 1.75 8.3
600 15 208 51.0 49.0 13.8 1.67 9.6
aPBB administered on day 6, 8, 10, 12, 14, and 16 of pregnancy in 100 mg/kg oral doses in I ml corn oil.
Results and Discussion
A highly significant increase ofgaps was detected
24 and 48 hr after treatment with 4.5 mg/kg oral dose
of TEM. After treatment with TEM, a highly sig-
nificant increase of multiple chromatid breaks and
cells with pulverized chromosomes, chromatid and
multiple chromatid breaks, and chromosome breaks
were detected 12, 24, and 48 hr, respectively. These
results show that the system used will detect
chromosome abnormalities if they are present. A
dose of 50 or 500 mg PBB/kg failed to increase sig-
nificantly chromosome or chromatid breaks, but 50
mg PBB/kg at 24 hr and 500 mg PBB/kg at 48 hr did
increase the number of gaps significantly (Table 1).
However the genetic significance of gaps is unclear
(8, 9).
Table 4. PBB-Colchicine synergism in pregnant rats for bone
marrow mitotic and metaphase endices.
Treatment Total
PBB, Colchicine, No. of no. of Metaphase Miotic
mg/kga mg/kgb animals cells index, % index, %
0 0 5 9977 0.46 2.16
0 5 5 6939 1.91e 5.37c
600 0 6 17825 0.55 2.20
600 5 6 5886 4.79" 12.40A
a PBB administered on day 6, 8, 10, 12, 14, and 16 of preg-
nancy in 100 mg/kg oral doses in 1 ml corn oil.
bColchicine administered on day 19 ofpregnancy 5 hr prior to
killing animals.
c Difference highly significant when compared to 0 mg/kg
PBB, 0 mg/kg colchicine treatment.
d Difference highly significant when compared to 0 mg/kg
PBB, 5 mg/kg colchicine treatment.
April 1978 131Mitotic index can serve as an indicator of the
bioavailability of the test compound or its metabo-
lites if a positive response occurs (5). PBB did not
increase either mitotic or metaphase index in mice
bone marrow (Table 2). Also, PBB did not show
synergism with colchicine in mice as reported ear-
lier in rats (6). We do not have an explanation for
synergism of PBB and colchicine in rats or of its
absence in mice. But it may be pertinent that PBB-
colchicine synergism in female rats was detected
after six oral doses of 100 mg/kg PBB suspended in
corn oil administered in two day intervals. The ani-
mals were killed 72 hr after the last treatment for
teratogenic and cytogenetic evaluations (6). (Tables
3 and 4). In contrast, male mice received single oral
doses of50 and 500 mg/kg PBB dissolved in DMSO,
and the animals were killed 12, 24, and 48 hr after
treatment for cytologic evaluations (Table 2).
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